Oral antivirals may reduce COVID-19 symptoms, progression, transmission, hospitalisation and mortality. We guide on successful deployment for Chief Pharmacists.

Use in patients taking interacting medicines, those with swallowing difficulties, or who are pregnant or breastfeeding, and signposting to patient advice.
Advice on swallowing difficulties, use in pregnancy and breastfeeding, and signposting to advice to give to patients.
Deployment should address a range of factors and be implemented through different mechanisms. Collecting data and learning will support continued safe use.